I recently had the opportunity to talk with Justin Zenanko, President & CEO of SynerFuse®, which is a cutting-edge, Minnesota-based medical device company innovating the spine industry with its integrated approach to spinal fusion and chronic low back & leg pain. The patented SynerFuse® e-TLIF™ Procedure combines fusion with direct nerve stimulation to address chronic low back and leg pain that enables Ultra Low Energy ™ (ULE™) Therapy that is unaddressed in traditional spinal fusion surgery.
SynerFuse® aims to address the fact that as many as 40% of spinal fusion procedures result in chronic, residual pain following a spinal fusion surgery, costing the U.S. healthcare system $20B annually. We discussed:· How the big strategics are leaving the opportunity for innovation to the small entrepreneurial companies like SynerFuse®.· How the SynerFuse® integrative technology stimulates the damaged nerves as part of spinal fusion surgery – a world-first approach.· Anecdotes from the SynerFuse® proof-of-concept study.· Why Justin has invested his own money into SynerFuse® and his advice to other unconventional entrepreneurs.